RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery
Effective nose-to-brain delivery needs to be developed to treat neurodegenerative diseases. Regulating miR-124 can effectively improve the symptoms of ischemic brain injury and provide a certain protective effect from brain damage after cerebral ischemia. We used rat models of middle cerebral artery...
Saved in:
Main Authors: | Rubin Hao (Author), Bixi Sun (Author), Lihua Yang (Author), Chun Ma (Author), Shuling Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis
by: Ruiyi Zhou, et al.
Published: (2022) -
Modified Stability of microRNA-Loaded Nanoparticles
by: Katja Fresacher-Scheiber, et al.
Published: (2022) -
Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
by: Eugene P. Chung, et al.
Published: (2020) -
Transforming growth factor-beta and microRNA-21, microRNA-29b, microRNA-92, and microRNA-129 in systemic sclerosis patients: a case-control study
by: Mohammed Hassan Mohammed, et al.
Published: (2022) -
MicroRNA-29b Suppresses Inflammation and Protects Blood-Brain Barrier Integrity in Ischemic Stroke
by: Xiaoqing Ma, et al.
Published: (2022)